Paul Mésange

Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension

Rasa Tamošiūnienė, Olga Manouvakhova, Paul Mésange et al. · Circulation Research · 2018 · 140 citations · Full text

Life Sciences, Immunology, Physiology +17

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

Christophe Tournigand, Benoist Chibaudel, Benoît Samson et al. · The Lancet Oncology · 2015 · 121 citations

Medicine, Oncology, Pharmacology +11

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor

Paul Mésange, Virginie Poindessous, Michèle Sabbah et al. · Oncotarget · 2014 · 80 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> Status

Paul Mésange, Anaïs Bouygues, Nathalie Ferrand et al. · Clinical Cancer Research · 2018 · 25 citations · Full text

Medicine, Oncology, Pharmacology +15

Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study

Benoist Chibaudel, Christophe Tournigand, Benoît Samson et al. · Annals of Oncology · 2014 · 10 citations

Medicine, Oncology, Pharmacology +11